Clarify the trigger
Name whether the concern is pathology, imaging, exam, tumor-marker context, known cancer history, recent Gyn Onc surgery, or a disposition barrier.
Gyn Onc consult triage
A concise triage aid for known or suspected gynecologic malignancy.
Common presentations
Before you consult
Name whether the concern is pathology, imaging, exam, tumor-marker context, known cancer history, recent Gyn Onc surgery, or a disposition barrier.
When the concern is a marker or incomplete imaging finding, collect the missing context first if the patient is stable and local pathways allow it.
Use local urgent pathways for instability, severe bleeding, obstruction, sepsis concern, acute postoperative complication, or another cannot-miss presentation.
Instead of asking whether a finding is abnormal, ask what decision Gyn Onc can help with today: biopsy route, staging, admission service, transfer, surgery, treatment planning, or outpatient timing.
Use this when the question involves known gyn cancer, suspicious pelvic or adnexal imaging, tissue diagnosis, tumor-marker context, postmenopausal bleeding, or gyn-onc disposition/referral timing.
Referral criteria and workup
Gyn Onc discussion is more likely to change care when there is confirmed gynecologic malignancy, active cancer-directed treatment, recent Gyn Onc surgery, highly suspicious adnexal or pelvic imaging, ascites or carcinomatosis with concern for gyn primary, or a biopsy-route, staging, disposition, or oncologic-surgery question. [1][2]
Initial workup or benign gynecology is usually the better first step when the question is an isolated tumor marker, incomplete adnexal imaging, symptoms without objective high-risk findings, or a likely benign/physiologic finding that needs standard gynecologic evaluation first. [1][2]
Clarify whether the trigger is pathology, imaging, exam, tumor-marker context, known cancer history, or a disposition constraint. The most useful consult asks what decision Gyn Onc can help answer today.
Include imaging impression and date, menopausal status when relevant, pathology or biopsy status, tumor-marker context, current acuity, active treatment or recent surgery, pending studies, and the specific question about admission service, transfer, biopsy route, staging, surgery, treatment planning, or outpatient timing.
Common low-yield consults
Copyable consult message
Reason for Consult: *** HPI: *** Clinical Question: *** Pending: *** Callback: *** Thank you!
Gyn Onc consults FAQ
No. Low-risk or clearly benign-appearing findings often follow benign gynecology or surveillance pathways. Gyn Onc becomes more relevant when imaging is highly suspicious, malignancy is confirmed, or surgical/staging decisions may change. [1][2]
Usually not by itself. Tumor markers are most useful in context with imaging, exam findings, menopausal status, symptoms, and pathology. Isolated lab concern often needs additional diagnostic workup first. [2]
It depends on the clinical picture. Confirmed gynecologic malignancy should generally prompt Gyn Onc involvement, but highly suspicious imaging can also justify early discussion before biopsy if the biopsy route, surgery, staging, or disposition may be affected. [1][2]
A focused consult question, concise oncologic history, key imaging or pathology, current acuity, disposition pressure, and pending studies. The most useful consult asks what decision needs Gyn Onc input today.
Educational tool only. SIC provides clinician-facing educational consult-triage references. SIC does not diagnose, treat, prevent, cure, or mitigate disease and is not a substitute for clinical judgment, local guidelines, institutional referral pathways, or recommendations from your gynecologic oncology department. See disclaimer and how SIC works.